BPIQ Blog

Jul 2, 20194 min read

ITCI - Investors Should Proceed with Caution with Imminent Phase 3 Readouts & FDA Decision In Co

Central nervous system (CNS) disorder drug development is a particularly difficult branch of biopharma drug development. ITCI has...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity

bottom of page